- Home
- Managing expenses
- Schemes and subsidies
- Cell, Tissue and Gene Therapy (CTGTP)
Cell, Tissue and Gene Therapy (CTGTP)
The Ministry of Health (MOH) provides subsidies for CTGTPs that have been assessed to be clinically- and cost-effective at our Public Healthcare Institutions.
Last updated 21 November 2024
Cell, Tissue and Gene Therapy Products (CTGTPs) list
The CTGTP list comprises CTGTPs assessed to be clinically- and cost-effective.
Subsidies for Cell, Tissue and Gene Therapy at public healthcare institutions
This page outlines CTGTP subsidies, benefits, and application details. Singapore Citizens can receive up to 75% off, while Permanent Residents get up to 22.5%, based on income levels.